Halozyme Therapeutics shares owned by Mesirow Institutional Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Mesirow Institutional Investment Management
from 13F filings
Historical chart of Mesirow Institutional Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Mesirow Institutional Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Halozyme Therapeutics by Mesirow Institutional Investment Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $15M | 290k | 52.36 |
2024-03-31 | $15M | 364k | 40.68 |
2023-12-31 | $17M | 454k | 36.96 |
2023-09-30 | $15M | 380k | 38.20 |
2023-06-30 | $15M | 423k | 36.07 |
2023-03-31 | $13M | 333k | 38.19 |
More positions owned by Mesirow Institutional Investment Management
View all positions for Mesirow Institutional Investment Management